FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

SEC EDGAR CompanyFacts fact · reporting period

NASUS PHARMA LTD.: xbrl:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

One fact, its scope and the complete path back to the official record.

Period: 2024-01-01 – 2024-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/7fc45f01-6e92-4572-b267-a27937f35f53

Reported value

$10.000k{"amount": 10000, "currency": "USD"}
Entity
NASUS PHARMA LTD.
Metric
xbrl:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
Period
2024-01-01 – 2024-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001493152-26-012559 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T19:06:39.902333+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
18% of job ads mention AI. Only 2% are AI jobs — and two thirds of the mentions come from 22 companies that say it in every ad.
Read the findingSearch 53 million companies